BIOMAT Database Logo BIOMAT Database Logo

Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors. 1994

P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Department of Pediatrics, Karolinska Hospital and Institute, Stockholm, Sweden.

Nerve growth factor (NGF) is suggested to play a role in spontaneous differentiation or regression of neuroblastoma. Expression of mRNAs for trk protooncogene and NGF low affinity receptor gene (LNGFR) were analyzed in 45 neuroblastomas with Northern Blot. Trk and LNGFR expression correlated with young age, localized tumors or IV-S disease, absence of N-myc amplification, triploid DNA content, spontaneous tumor regression and favorable prognosis. Regardless of other factors, trk and LNGFR mRNAs distinguished three prognostic subsets: one favorable (trk+, LNGFR+, n = 19, 100% survival probability), one intermediate (trk+, LNGFR-, n = 11, 62%) and one poor (trk-, n = 15, 0%). An algorithm based on the combined analysis of trk and LNGFR mRNAs and DNA ploidy divided the material in two groups with 96 and 0% survival probability respectively (p < 0.001), and predicted outcome accurately in 43 of 45 children. It is hypothesized that loss of functional NGF-receptors constitutes an early critical step in the evolution of unfavorable neuroblastomas prone to progression in spite of current therapy.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Tissue Localization of Nerve Growth Factor Receptors: trk A and Low-Affinity Nerve Growth Factor Receptor in Neuroblastoma, Pheochromocytoma, and Retinoblastoma.
January 1996, Endocrine pathology,
P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Expression of a Trk high affinity nerve growth factor receptor in the human prostate.
January 1995, Endocrinology,
P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease.
May 2000, Gut,
P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
January 1994, Progress in clinical and biological research,
P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells.
January 2002, Neurology & clinical neurophysiology : NCN,
P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Expression of trk in MAH cells lacking the p75 low-affinity nerve growth factor receptor is sufficient to permit nerve growth factor-induced differentiation to postmitotic neurons.
April 1994, Proceedings of the National Academy of Sciences of the United States of America,
P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma.
January 1995, European journal of cancer (Oxford, England : 1990),
P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.
January 1994, Progress in clinical and biological research,
P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Expression of Low Affinity Nerve Growth Factor Receptor p75 in Classic Bladder Exstrophy.
January 2021, Frontiers in pediatrics,
P Kogner, and G Barbany, and O Björk, and M A Castello, and A Donfrancesco, and U G Falkmer, and F Hedborg, and H Kouvidou, and H Persson, and G Raschella
Localization of trkB and low-affinity nerve growth factor receptor mRNA in the developing rat retina.
February 1995, Neuroscience letters,
Copied contents to your clipboard!